About Certest Biotec
Certest Biotec is a company based in Zaragoza (Spain) founded in 2002. It operates as a B2B. Certest Biotec offers products and services including Rapid Test, Turbilatex, VIASURE, and NGS Solutions.
Products & Services of Certest Biotec
Certest Biotec offers a comprehensive portfolio of products and services, including Rapid Test, Turbilatex, VIASURE, and NGS Solutions.
One-step tests for detecting infectious disease antigens
Solutions for faecal antigen detection in clinical settings
Real-time PCR kits for pathogen identification in labs
Kits for simplifying next-generation sequencing workflows
Apps and channels of Certest Biotec
its YouTube channel Certest Biotec, S.L. has 2.54K subscribers and 30 videos.
Videos from Certest Biotec
The most watched videos on Certest Biotec's YouTube channel, Certest Biotec, S.L. (2.54K subscribers). Click a video to play it here.
More on Certest Biotec, S.L..
People of Certest Biotec
14 people are tracked at Certest Biotec (3 in leadership, 11 in team).
| Name | Role | Group |
|---|---|---|
Óscar Landeta | CEO and founding partner | Leadership |
Vanesa Tomás Zapatero | Chief Financial Officer | Leadership |
Juan Martínez Oliván | Chief Scientific Officer | Leadership |
Virginia Mógica Callao | Técnico En Gestión De Laboratorio (departamento Bioscience) | Team |
Laura Iguacel Quintana | Investigadora, I+ D Diagnóstico Molecular | Team |
Mónica Garcés Lardiés | Controller Financiero | Team |
Miriam Labrador Bernad | Research & Innovation Project Management | Team |
Eduardo Laga Lázaro | Responsable De Departamento E Investigador | Team |
Laura Llobet Sesé | R&d Molecular Diagnostics Manager | Team |
Lucía Gracia Carmona | Técnico De Laboratorio I+d Biología Molecular | Team |
Sergio Pinilla Zapater | Responsable De Administración | Team |
Laura Solanas Laguna | Responsable De Control De Calidad | Team |
Fernando Alcolea Guallar | Development And Innovation Department | Team |
Marta Cajo | Quality Assurance | Team |
Complete people profiles for Certest Biotec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Certest Biotec
Websites that share an audience with Certest Biotec (certest.es).
Websites whose visitors overlap most with Certest Biotec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| phasescientific.com | 100% | 4K | – | View details |
Latest news on Certest Biotec
Complete news archive for Certest Biotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Certest Biotec
10 companies that operate in the same segment as Certest Biotec (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Certest Biotec
Certest Biotec was founded in 2002.
Certest Biotec is headquartered in Zaragoza, Spain. It is registered at Zaragoza, Aragon, Spain.
Certest Biotec develops and supplies raw materials for immunodiagnostic and molecular diagnostic applications, including rapid tests and PCR kits. They focus on simplifying lab processes for infectious disease detection through innovative solutions like turbidimetry and next-generation sequencing. Based in Spain, their products target professional healthcare settings, ensuring efficiency and reliability in diagnostics without direct consumer sales.
Certest Biotec offers Rapid Test, Turbilatex, VIASURE, and NGS Solutions.